Scientists have developed an experimental RNA-based drug, TY1, that repairs DNA, reduces scar tissue and could lead to new ...

Learn how Logic-gated DARPins work to activate T cells selectively in solid tumours, enhancing therapeutic outcomes.

Discover how Fibulin-5 could serve as a new blood-based marker for early liver fibrosis diagnosis and potential treatment ...

Explore how epilepsy target SV2A interacts with anti-epilepsy drugs in groundbreaking research using cryo-electron microscopy ...

Explore the innovative method for producing lung organoids aimed at enhancing treatment for respiratory diseases effectively.

Explore how pre-transplant treg therapy can enhance stem cell transplant safety and boost survival rates for blood cancer ...

Insilico Medicine has announced ISM3830, an AI-designed CBLB inhibitor that has demonstrated promising preclinical results.

Explore the fibrosis mechanism in NPHP and how blocking cellular pathways can reduce kidney scarring in children.

Understand how paclitaxel works against cancer cells and its significant role in chemotherapy for breast cancer.

BCG’s Chris Meier outlines how advances in AI and new UK policies could accelerate drug development, streamline clinical trials and strengthen the country’s life sciences sector. Every year, ...

A new CAR-T treatment developed in Switzerland has shown striking early success against glioblastoma, one of the deadliest brain cancers, and is now moving towards human trials. Glioblastoma typically ...

Everyone talks about AI speeding up drug discovery, but Eric Ma explains why, without clean data and statistical discipline, it can actually do the opposite. Eric Ma, a data science lead for Moderna’s ...